Back
Enanta Pharmaceuticals Vs. Viking Therapeutics Industry Stock Comparison
Sell
26
ENTA
Enanta Pharmaceuticals
Last Price:
12.62
Seasonality Move:
-0.7%
Buy
63
VKTX
Viking Therapeutics
Last Price:
73.66
Seasonality Move:
16.43%
Sell
26
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $12.65. The Score for ENTA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $73.64. The Score for VKTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $12.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $73.64
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
ENTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 40.07 | Sell |
| Chaikin Money Flow: | -93495 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.71 - 15.69) | Sell |
| Bollinger Bands (100): | (11.22 - 15.34) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 50.61 | Buy |
| Chaikin Money Flow: | -3478419 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.56 - 77.6) | Buy |
| Bollinger Bands (100): | (24.84 - 76.58) | Buy |
ENTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.59 | Sell |
| 20-day SMA: | 13.6 | Sell |
| 50-day SMA: | 14.76 | Sell |
| 200-day SMA: | 12.58 | Buy |
| 8-day EMA: | 13.27 | Sell |
| 20-day EMA: | 13.77 | Sell |
| 50-day EMA: | 14.04 | Sell |
| 200-day EMA: | 16.19 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.59 | Sell |
| 20-day SMA: | 72.11 | Buy |
| 50-day SMA: | 73.48 | Buy |
| 200-day SMA: | 31.83 | Buy |
| 8-day EMA: | 76.82 | Sell |
| 20-day EMA: | 74.46 | Sell |
| 50-day EMA: | 67.93 | Buy |
| 200-day EMA: | 40.82 | Buy |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.36 per share, and an increase next year of $0.46 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.41 per share.
Enanta Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||